What Happened To Arterys Cardio Ai: Post-Mortem and Best Alternatives (2026)

The Short Version

Arterys Cardio AI no longer operates as a standalone product. Tempus acquired Arterys in October 2022. Its technology became part of Tempus's medical-imaging portfolio. The original Arterys website now redirects to Tempus. Therefore, Arterys Cardio AI does not work today as a separate tool. Users seeking similar functionality will need to explore alternatives.

What Arterys Cardio AI Was

Arterys Cardio AI was a specialized healthcare technology product. It offered cloud-based software for cardiac MRI analysis. The system used machine learning algorithms. These algorithms helped clinicians with complex tasks. It assisted in image segmentation, for example. It also provided ventricular measurements and cardiac function assessments. This technology was crucial for improving diagnostic accuracy. It aimed to streamline workflows for cardiologists. The tool played a significant role in advanced medical imaging. It provided significant value to the healthcare sector.

The Timeline

The history of Arterys Cardio AI includes several key milestones. The product was launched at an unknown date. On January 5, 2017, Cardio AI received FDA clearance. This clearance was for its cloud-based application. It used deep learning for cardiac MRI analysis. Later that year, on November 2, 2017, Arterys announced its Series B funding. This round totaled $30 million. Temasek led the funding. GE Ventures and Fosun also participated. On May 5, 2020, a Series C round was announced. It raised $28 million. Benslie Investment Group and Temasek led this round. The funds were for expanding the medical-imaging AI platform. The final recorded event was on October 4, 2022. Tempus announced its acquisition of Arterys. The acquisition aimed to integrate Arterys's AI capabilities. This would enhance Tempus's precision-medicine platform. /tools/arterys-cardio-ai

What We Know About Why It Ended

Arterys Cardio AI did not shut down due to failure. It was acquired by Tempus AI, Inc. in October 2022. Tempus announced the acquisition publicly. This move was strategic for Tempus. The goal was to incorporate Arterys's cloud-based medical-imaging AI capabilities. These capabilities would enhance Tempus's existing platform. The former Arterys homepage now directs to Tempus's website. The acquisition meant Arterys technology was folded into Tempus's offerings. No specific explanation for the acquisition was published by the company. However, the recorded reason indicates a strategic integration. This integration aimed to expand Tempus's medical-imaging portfolio.

Who It Hurt, and What Broke

The acquisition of Arterys Cardio AI likely impacted existing users. Clinicians relied on its specific features for cardiac MRI analysis. They would have faced a transition period. Integrations with other hospital systems might have changed. Data export procedures could have been affected. Users might have needed to migrate historical data. Billing structures and support channels also changed. Access to the original Arterys Cardio AI platform ceased. Users had to adapt to new workflows under Tempus. This process can be disruptive for healthcare providers. It requires learning new systems. It means adjusting established clinical practices.

Drop-In Replacements

Healthcare professionals seeking alternatives to Arterys Cardio AI have options. These tools may not replicate every feature. However, they offer similar functionalities in the broader AI and medical imaging space. Exploring these can help maintain continuity.

Akkio: Best for General AI and Automation

Akkio is a versatile AI platform. It focuses on general AI applications. It helps users build and deploy AI models quickly. It can automate various data tasks. However, Akkio is not specialized in cardiac MRI analysis. It does not replace the specific medical imaging features of Arterys Cardio AI. Akkio is more suited for broad business intelligence. Visit the official Akkio website at https://www.akkio.com/.

Hugging Face: Best for AI Model Development

Hugging Face offers a platform for machine learning development. It provides open-source tools and models. Developers can build custom AI solutions. It is excellent for research and advanced AI projects. It does not offer out-of-the-box cardiac analysis. Users would need to develop or adapt models. This requires significant technical expertise. It is not a direct, ready-to-use replacement. Learn more at https://huggingface.co/.

Obviously AI: Best for No-Code Predictive Analytics

Obviously AI simplifies AI for non-developers. It enables predictive analytics without coding. Users can upload data and get insights. This tool is user-friendly for various industries. It lacks the specialized medical imaging capabilities. It does not perform cardiac MRI segmentation. It is not a direct substitute for clinical diagnostic software. Explore Obviously AI at https://www.obviously.ai/.

• For more specialized medical imaging AI tools, clinicians should research the current market. Focus on platforms with FDA clearances for cardiac analysis. /is-arterys-cardio-ai-dead /what-happened-to-arterys-cardio-ai

How to Migrate Without Losing Work

Migrating from a discontinued or acquired platform requires careful planning. This is especially true in healthcare. The goal is to ensure data integrity and continuity of care. Here is a checklist for a smooth transition:

• Export all patient data: Securely download or transfer all historical cardiac MRI reports. Ensure all relevant measurements and segmentations are included. This prevents data loss. Adhere to all patient privacy regulations.
• Archive past analyses: Keep a complete record of all analyses performed. This includes raw images and AI-generated results. Store them in a compliant, accessible archive.
• Review existing integrations: Identify any systems connected to Arterys Cardio AI. Plan for their disconnection or re-integration with new software. This prevents workflow interruptions.
• Communicate with the new provider: Contact Tempus or your chosen alternative. Understand their data migration policies. Inquire about their support for transitioning historical data.
• Train staff on new tools: Provide comprehensive training for all users. This ensures proficiency with the replacement system. Minimize disruption to clinical operations.
• Validate new system results: Compare results from the new tool with archived Arterys Cardio AI data. Confirm accuracy and consistency. This maintains diagnostic quality.

Starting early is essential. Careful documentation throughout the process is also vital. This ensures a successful migration.

Lessons for Anyone Building in Healthcare

The story of Arterys Cardio AI offers insights for AI innovators in healthcare. The journey from FDA clearance to acquisition highlights several critical points. These lessons are valuable for any startup.

• Regulatory clearance is paramount: Achieving FDA 510(k) clearance was a significant milestone. It validated the technology for clinical use. This is crucial for market entry in healthcare.
• Strategic partnerships drive growth: Early investment from entities like GE Ventures showed strong industry belief. Such partnerships can open doors. They provide resources and credibility.
• Specialization creates value: Arterys focused on a niche: cardiac MRI analysis. This deep specialization made it an attractive acquisition target. It offered unique capabilities.
• Acquisition can be a successful exit: An acquisition by a larger entity like Tempus is not a failure. It often represents a successful integration. It expands the reach of the technology.
• Integration is a core business strategy: Companies like Tempus seek to consolidate cutting-edge tech. Startups should consider how their product fits into larger platforms. This prepares them for potential acquisitions.
• Market validation attracts investment: Multiple funding rounds (Series B, Series C) demonstrate investor confidence. This confidence comes from product performance and market potential. This shows the success of the arterys cardio ai acquisition. /tools/akkio